A detailed history of New Edge Wealth, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, New Edge Wealth, LLC holds 7,215 shares of CORT stock, worth $545,021. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,215
Previous 5,948 21.3%
Holding current value
$545,021
Previous $436,000 37.39%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$67.17 - $83.9 $85,104 - $106,301
1,267 Added 21.3%
7,215 $599,000
Q2 2025

Aug 11, 2025

SELL
$62.24 - $91.93 $557,608 - $823,600
-8,959 Reduced 60.1%
5,948 $436,000
Q1 2025

May 09, 2025

BUY
$49.85 - $114.22 $118,991 - $272,643
2,387 Added 19.07%
14,907 $1.7 Million
Q4 2024

Feb 04, 2025

BUY
$44.66 - $60.85 $337,763 - $460,208
7,563 Added 152.57%
12,520 $630,000
Q3 2024

Nov 12, 2024

BUY
$29.51 - $46.26 $146,281 - $229,310
4,957 New
4,957 $229,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $8.09B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track New Edge Wealth, LLC Portfolio

Follow New Edge Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Wealth, LLC with notifications on news.